Scaling excellence: Samsung Biologics’ vision for the next era of biomanufacturing
Samsung Biologics is scaling biomanufacturing through a core philosophy of Standardization, Scalability, and Simplification, while expanding into cell and gene therapies with dedicated investments in viral vector GMP capacity and AAV production. The company is integrating digital twins, agentic AI, and robotics across operations, alongside sustainability leadership through SBTi-aligned decarbonization and RE100 renewable electricity goals. Samsung Biologics is positioning itself as a strategic partner capable of delivering predictable supply chains across complex global networks.
Explore the full feature to learn how these innovations are shaping the next era of biologics manufacturing.
Samsung Biologics is scaling biomanufacturing through a core philosophy of Standardization, Scalability, and Simplification, while expanding into cell and gene therapies with dedicated investments in viral vector GMP capacity and AAV production. The company is integrating digital twins, agentic AI, and robotics across operations, alongside sustainability leadership through SBTi-aligned decarbonization and RE100 renewable electricity goals. Samsung Biologics is positioning itself as a strategic partner capable of delivering predictable supply chains across complex global networks.
Explore the full feature to learn how these innovations are shaping the next era of biologics manufacturing.
Share article
Related Content